639 related articles for article (PubMed ID: 25986745)
1. Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?
Gupta M; Mahajan VK; Mehta KS; Chauhan PS; Rawat R
Arch Dermatol Res; 2015 Nov; 307(9):767-80. PubMed ID: 25986745
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease.
Michalik L; Wahli W
Biochim Biophys Acta; 2007 Aug; 1771(8):991-8. PubMed ID: 17400022
[TBL] [Abstract][Full Text] [Related]
4. The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology.
Ramot Y; Mastrofrancesco A; Camera E; Desreumaux P; Paus R; Picardo M
Exp Dermatol; 2015 Apr; 24(4):245-51. PubMed ID: 25644500
[TBL] [Abstract][Full Text] [Related]
5. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
Yessoufou A; Wahli W
Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptors in cutaneous biology.
Kuenzli S; Saurat JH
Br J Dermatol; 2003 Aug; 149(2):229-36. PubMed ID: 12932225
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors and their relevance to dermatology.
Friedmann PS; Cooper HL; Healy E
Acta Derm Venereol; 2005; 85(3):194-202. PubMed ID: 16040401
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
9. [Development of a cell-based peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of triterpenoids isolate from Alismatis Rhizoma].
Li XY; Wang XH; Huang XQ; Wu TT; Xu W; Wu SS
Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):4015-4022. PubMed ID: 28929690
[TBL] [Abstract][Full Text] [Related]
10. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?
Weindl G; Schäfer-Korting M; Schaller M; Korting HC
Drugs; 2005; 65(14):1919-34. PubMed ID: 16162018
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
Aleshin S; Strokin M; Sergeeva M; Reiser G
Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte differentiation and upregulation of ceramide synthesis induced by an oat lipid extract via the activation of PPAR pathways.
Chon SH; Tannahill R; Yao X; Southall MD; Pappas A
Exp Dermatol; 2015 Apr; 24(4):290-5. PubMed ID: 25651930
[TBL] [Abstract][Full Text] [Related]
14. Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
Chopra B; Georgopoulos NT; Nicholl A; Hinley J; Oleksiewicz MB; Southgate J
Cell Prolif; 2009 Oct; 42(5):688-700. PubMed ID: 19614673
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
Guan Y; Breyer MD
Kidney Int; 2001 Jul; 60(1):14-30. PubMed ID: 11422732
[TBL] [Abstract][Full Text] [Related]
16. Various peroxisome proliferator-activated receptor (PPAR)-γ agonists differently induce differentiation of cultured human keratinocytes.
Yan Y; Furumura M; Numata S; Teye K; Karashima T; Ohyama B; Tanida N; Hashimoto T
Exp Dermatol; 2015 Jan; 24(1):62-5. PubMed ID: 25346431
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
18. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.
Sertznig P; Reichrath J
Dermatoendocrinol; 2011 Jul; 3(3):130-5. PubMed ID: 22110772
[TBL] [Abstract][Full Text] [Related]
20. Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease.
Montagner A; Wahli W
Biomol Concepts; 2013 Feb; 4(1):53-64. PubMed ID: 25436565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
